840 related articles for article (PubMed ID: 1174047)
1. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
Heinrich HC
Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
Kaltwasser JP; Werner E; Niechzial M
Arzneimittelforschung; 1987 Jan; 37(1A):122-9. PubMed ID: 3566867
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability of iron from oral ferric polymaltose in humans.
Nielsen P; Gabbe EE; Fischer R; Heinrich HC
Arzneimittelforschung; 1994 Jun; 44(6):743-8. PubMed ID: 8053973
[TBL] [Abstract][Full Text] [Related]
4. [Investigations of the bioavailability of iron from bi- and trivalent iron salts (author's transl)].
Dietzfelbinger H; Kaboth W
Med Klin; 1977 Apr; 72(15):654-9. PubMed ID: 853979
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of bi- and trivalent oral iron preparations. Investigations of iron absorption by postabsorption serum iron concentrations curves.
Dietzfelbinger H
Arzneimittelforschung; 1987 Jan; 37(1A):107-12. PubMed ID: 3566864
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of bio-availability, antianaemic efficacy, tolerance and drug costs in oral iron(II) and iron(III) preparations (author's transl)].
Dietzfelbinger H; Kaboth W
Med Klin; 1979 Nov; 74(48):1818-24. PubMed ID: 395435
[TBL] [Abstract][Full Text] [Related]
7. Iron pharmacokinetics after administration of ferric-hydroxide-polymaltose complex in rats.
Geisser P; Müller A
Arzneimittelforschung; 1984; 34(11):1560-9. PubMed ID: 6543131
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of iron salts and ferric hydroxide-carbohydrate complexes.
Geisser P; Müller A
Arzneimittelforschung; 1987 Jan; 37(1A):100-4. PubMed ID: 3566862
[TBL] [Abstract][Full Text] [Related]
9. Intestinal absorption of 59Fe from neutron-activated commercial oral iron(III)-citrate and iron(III)-hydroxide-polymaltose complexes in man.
Heinrich HC
Arzneimittelforschung; 1987 Jan; 37(1A):105-7. PubMed ID: 3566863
[TBL] [Abstract][Full Text] [Related]
10. On the absorption of divalent and trivalent iron in living rats.
Schäfer S; Forth W
Arzneimittelforschung; 1984; 34(11):1570-4. PubMed ID: 6543132
[TBL] [Abstract][Full Text] [Related]
11. Iron absorption by human subjects from different iron fortification compounds added to Thai fish sauce.
Walczyk T; Tuntipopipat S; Zeder C; Sirichakwal P; Wasantwisut E; Hurrell RF
Eur J Clin Nutr; 2005 May; 59(5):668-74. PubMed ID: 15756294
[TBL] [Abstract][Full Text] [Related]
12. [Bioavailability of iron in oral iron preparations. Principles of duration and dosage (author's transl)].
Heinrich HC; Gabbe EE
MMW Munch Med Wochenschr; 1979 Aug; 121(35):1104-8. PubMed ID: 114773
[TBL] [Abstract][Full Text] [Related]
13. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose.
Jacobs P; Johnson G; Wood L
J Med; 1984; 15(5-6):367-77. PubMed ID: 6599114
[TBL] [Abstract][Full Text] [Related]
14. On the therapeutic effects of trivalent and divalent iron in iron deficiency anaemia.
Sas G; Nemesanszky E; Bräuer H; Scheffer K
Arzneimittelforschung; 1984; 34(11):1575-9. PubMed ID: 6543133
[TBL] [Abstract][Full Text] [Related]
15. [Is ferric ion absorbed? Absorption of ferrous and ferric ions in healthy subjects and anemic patients].
Heyder N; Waldherr A; Hartwich G
Fortschr Med; 1982 Jul; 100(26):1259-61. PubMed ID: 7118034
[No Abstract] [Full Text] [Related]
16. Iron deficiency up-regulates iron absorption from ferrous sulphate but not ferric pyrophosphate and consequently food fortification with ferrous sulphate has relatively greater efficacy in iron-deficient individuals.
Zimmermann MB; Biebinger R; Egli I; Zeder C; Hurrell RF
Br J Nutr; 2011 Apr; 105(8):1245-50. PubMed ID: 21205385
[TBL] [Abstract][Full Text] [Related]
17. Equivalent bioavailability of iron from ferrous salts and a ferric polymaltose complex. Clinical and experimental studies.
Jacobs P
Arzneimittelforschung; 1987 Jan; 37(1A):113-6. PubMed ID: 3566865
[TBL] [Abstract][Full Text] [Related]
18. [Intestinal absorption from therapeutic iron doses (author's transl)].
Werner E; Kaltwasser JP; Ihm P
Arzneimittelforschung; 1976; 26(11):2093-100. PubMed ID: 1037255
[TBL] [Abstract][Full Text] [Related]
19. Effects of iron(II) salts and iron(III) complexes on trace element status in children with iron-deficiency anemia.
Sözmen EY; Kavakli K; Cetinkaya B; Akçay YD; Yilmaz D; Aydinok Y
Biol Trace Elem Res; 2003 Jul; 94(1):79-86. PubMed ID: 12907830
[TBL] [Abstract][Full Text] [Related]
20. Ferrous sulfate reduces methyldopa absorption: methyldopa: iron complex formation as a likely mechanism.
Campbell NR; Campbell RR; Hasinoff BB
Clin Invest Med; 1990 Dec; 13(6):329-32. PubMed ID: 2078911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
